Home » Stocks » CCEL

Cryo-Cell International Inc. (CCEL)

Stock Price: $7.68 USD 0.14 (1.79%)
Updated November 20, 3:32 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 57.91M
Revenue (ttm) 31.58M
Net Income (ttm) 3.27M
Shares Out 7.55M
EPS (ttm) 0.40
PE Ratio 19.19
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 20
Last Price $7.68
Previous Close $7.54
Change ($) 0.14
Change (%) 1.79%
Day's Open 7.60
Day's Range 7.54 - 7.80
Day's Volume 11,460
52-Week Range 5.5 - 9.93

More Stats

Market Cap 57.91M
Enterprise Value 56.81M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 7.55M
Float 3.15M
EPS (basic) 0.42
EPS (diluted) 0.40
FCF / Share 0.81
Dividend n/a
Dividend Yield n/a
Earnings Yield 5.21%
FCF Yield 10.59%
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.22
PE Ratio 19.19
Forward PE n/a
P/FCF Ratio 9.45
PS Ratio 1.83
PB Ratio n/a
Revenue 31.58M
Operating Income 6.92M
Net Income 3.27M
Free Cash Flow 6.13M
Net Cash 1.11M
Net Cash / Share 0.15
Gross Margin 61.59%
Operating Margin 21.93%
Profit Margin 10.40%
FCF Margin 19.42%
ROA 10.03%
ROE n/a
ROIC 23.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $7.68
Target: 5.28
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth8.89%15.1%9.76%9.66%4.79%5.96%5.7%0.29%0.88%-
Gross Profit21.7820.6818.6617.3515.4614.4913.6713.0813.5213.26
Operating Income4.324.775.010.432.931.981.70-1.71-0.283.35
Net Income2.29-0.852.32-1.328.110.550.03-6.31-2.103.46
Shares Outstanding7.797.467.068.119.5410.1810.8611.3111.7611.75
Earnings Per Share0.27-0.110.30-0.160.830.05--0.56-0.180.29
EPS Growth----1560%-----
Operating Cash Flow6.325.335.724.994.851.550.820.360.822.34
Capital Expenditures-0.66-0.65-0.10-0.34-0.11-0.12-0.35-0.13-0.51-0.40
Free Cash Flow5.664.695.624.644.741.430.470.230.311.94
Cash & Equivalents7.456.926.724.124.973.595.485.8210.019.70
Total Debt8.9612.947.309.821.18-----
Net Cash / Debt-1.51-6.03-0.58-5.703.793.595.485.8210.019.70
Book Value-6.95-8.91-12.50-15.41-4.96-10.73-9.27-9.00-2.46-1.00
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cryo-Cell International Inc.
Country United States
Employees 87
CEO Mark L. Portnoy / David I. Portnoy

Stock Information

Ticker Symbol CCEL
Stock Exchange US OTC
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier OTCMKTS: CCEL
IPO Date January 21, 1997


Cryo-Cell International engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.